Skip to main content

Targeted drugs shrink breast cancer tumors in mice without toxic side effects

NewsColony
Targeted drugs shrink breast cancer tumors in mice without toxic side effects

A team of researchers led by Worcester Polytechnic Institute (WPI) Provost Wole Soboyejo has identified targeted drugs that reduced the sizes of hard-to-treat breast cancer tumors in mice without inducing the toxic side effects that are typically associated with conventional chemotherapy.

The researchers said in an article published in Scientific Reports that a molecular recognition unit attached to drugs specifically targeted “triple-negative” breast cancer tumors, which typically do not respond to targeted therapies. The targeted drugs eliminated or reduced the sizes of breast cancer tumors in laboratory experiments that were performed on mice. No toxic side effects were observed in the experiments.

When injected into the bloodstream, only a small fraction of traditional chemotherapeutic drugs reaches tumors. It usually takes relatively high concentrations of conventional cancer drugs to have therapeutic effects on tumors. Hence, such concentrations are often toxic to other cells. In our case, the targeting drugs were more effective at shrinking and eliminating triple-negative breast tumors in mice. They also eliminated tumors without inducing toxicity.”

Wole Soboyejo, Worcester Polytechnic Institute

Breast cancer is the most commonly diagnosed cancer in women. Chemotherapy kills fast-growing tumor cells by flooding a patient’s body with potent drugs, but the treatment often produces toxic side effects. Targeted therapy aims to reduce side effects by delivering chemotherapeutic drugs directly to breast cancer tumor cells. The drugs seek out and bind to specific cellular structures known as receptors.

Three common receptors that are over-expressed on the surfaces of breast cancer tumor cells are HER2, a growth factor, as well as estrogen and progesterone hormones. Most breast cancer treatments target HER2 receptors. However, between 10% and 17% of all breast cancers lack HER2, estrogen, and progesterone receptors. These “triple-negative” breast cancers are more prevalent in younger women, African American women, and African women.

Related Stories

Soboyejo, inspired by a relative’s battle with breast cancer, previously studied luteinizing hormone-releasing hormone (LHRH) as a targeting mechanism to deliver magnetic nanoparticles to breast tumors. The targeted magnetic nanoparticles were found to improve the imaging of breast tumors in nude mice, a type of laboratory mouse. LHRH is a naturally occurring hormone in mammals. It is essential for reproduction.

More recently, Soboyejo began studying LHRH as a targeting mechanism for chemotherapeutic drugs. His work has been funded by WPI and the Pan African Materials Institute at the African University of Science and Technology (AUST) in Abuja, Nigeria, which is funded by the World Bank.

In this study, the researchers attached the chemotherapy drug paclitaxel to LHRH. They also attached prodigiosin, a natural substance with anti-cancer properties, to LHRH. Both combination molecules were tested against triple-negative breast cancer cells and tissues.

Soboyejo’s team hopes to continue work on LHRH-targeted nanoparticles and therapeutic drugs, and to position them for human clinical trials on breast cancer patients. The group is also working to identify other targeted drugs and nanoparticles for the detection and treatment of other tumors.

“The fact that we could target triple-negative breast cancer in mice models is important. However, I think this method has major implications for targeted cancer treatment in general,” Soboyejo said.

Journal reference:

Obayemi, J.D., et al. (2020) LHRH-Conjugated Drugs as Targeted Therapeutic Agents for the Specific Targeting and Localized Treatment of Triple Negative Breast Cancer. Scientific Reports. doi.org/10.1038/s41598-020-64979-1.

Source: | Medical News

Source: Sound Health and Lasting Wealth

The post Targeted drugs shrink breast cancer tumors in mice without toxic side effects appeared first on NewsColony.
NewsColony



source https://newscolony.com/targeted-drugs-shrink-breast-cancer-tumors-in-mice-without-toxic-side-effects/

Comments

Popular posts from this blog

Volunteers book hotel room for homeless man with SingapoRediscovers vouchers

NewsColony Volunteers book hotel room for homeless man with SingapoRediscovers vouchers © The Independent Singapore Singapore — A group of volunteers from the Mummy Yummy Singapore welfare organisation donated their SingapoRediscovers Vouchers to book a hotel room for a homeless man. The man, who was identified as Jayden, did not have a place to live while waiting for the Housing Board (HDB) to allocate him a rental flat. In a Facebook post on Mummy Yummy Singapore’s page on Wednesday (Dec 16), the volunteers said: “We used our $100 Rediscover Singapore vouchers to redeem hotel stay for him and successfully booked 9 days worth of stay at 3 days per voucher.” They added that they were unable to book a longer stay because of higher hotel rates over Christmas and New Year. The volunteers hoped that they would be able to bridge Jayden’s stay until he got a flat. “Thanks our government for giving us these vouchers which in return we can put them to good use for people in need,” th...

Disabled people are still vulnerable, even as COVID-19 normalizes their ‘special’ needs

Disabled people are still vulnerable, even as COVID-19 normalizes their ‘special’ needs NewsColony Perhaps it’s appropriate that public notices of the COVID-19 crisis began as an ableist cruelty. Health officials assured the nation that only the elderly and those with chronic health conditions would be seriously affected; most Americans (i.e., the normal people) would have only mild symptoms and be fine. x A friendly reminder: people who will be high-risk patients if we get coronavirus can hear you when you reassure everyone we’re the only ones who might die. â€Â” Alexandra Brodsky (@azbrodsky) February 29, 2020 Soon after the announcement of those assurances, the likelihood of high-risk people surviving was further limited by the people more likely to be fine. Shopping frenzies cleared stores of essential supplies needed everyday by many disabled people, like thermometers, hand wipes, masks, and IV infusion supplies. Accustomed to their needs ...

Coronavirus UK: BBC makes changes to ‘lift people’s spirits’

Coronavirus UK: BBC makes changes to ‘lift people’s spirits’ NewsColony BBC viewers have been warned that ‘things will look and sound a bit different’ during the coronavirus crisis.  In a blog post on the corporation’s website, BBC News Chief Fran Unsworth outlined a number of changes its newsroom was making in light of the ‘rapidly evolving situation’.   Among the changes, presenters will doing their own make-up, many interviews will be conducted remotely and the BBC will rely more on its network of local reporters, Ms Unsworth explained. TV veterans Mr Motivator and Angela Rippon have also signed up for a new BBC One show to lift people’s spirits during the pandemic. HealthCheck UK Live, with Watchdog’s Michelle Ackerley and CBBC star Dr Xand van Tulleken will air every weekday for two weeks. TV veterans Mr Motivator and Angela Rippon have also signed up for a new BBC One show to lift people’s spirits during the pandemic HealthCheck UK Live, with Wa...